Why this ASX 200 stock is a retirees dream - The Motley Fool Australia
SKHHY Stock | USD 18.51 0.38 2.10% |
Slightly above 55% of Sonic Healthcare's investors are presently thinking to get in. The analysis of overall sentiment of trading Sonic Healthcare Ltd pink sheet suggests that some investors are interested at this time. Sonic Healthcare's investing sentiment can be driven by a variety of factors including economic data, Sonic Healthcare's earnings reports, geopolitical events, and overall market trends.
Sonic |
Why this ASX 200 stock is a retirees dream The Motley Fool Australia
Read at news.google.com
Sonic Healthcare Fundamental Analysis
We analyze Sonic Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sonic Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sonic Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Sonic Healthcare is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Sonic Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sonic Healthcare pink sheet to make a market-neutral strategy. Peer analysis of Sonic Healthcare could also be used in its relative valuation, which is a method of valuing Sonic Healthcare by comparing valuation metrics with similar companies.
Peers
Sonic Healthcare Related Equities
MYNZ | Mainz Biomed | 9.52 | ||||
BDSX | Biodesix | 8.27 | ||||
INBS | Intelligent Bio | 6.62 | ||||
CDNA | Caredx | 4.19 | ||||
CSTL | Castle Biosciences | 3.59 | ||||
NTRA | Natera | 2.39 | ||||
PRPH | ProPhase Labs | 1.35 | ||||
PRPO | Precipio | 0.85 | ||||
FONR | Fonar | 0.18 | ||||
QGEN | Qiagen NV | 0.02 | ||||
TWST | Twist Bioscience | 0.13 | ||||
PRE | Prenetics Global | 0.22 | ||||
CRL | Charles River | 1.76 | ||||
STIM | Neuronetics | 2.06 | ||||
LZAGF | Lonza Group | 3.88 | ||||
APDN | Applied DNA | 5.88 |
Additional Tools for Sonic Pink Sheet Analysis
When running Sonic Healthcare's price analysis, check to measure Sonic Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonic Healthcare is operating at the current time. Most of Sonic Healthcare's value examination focuses on studying past and present price action to predict the probability of Sonic Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonic Healthcare's price. Additionally, you may evaluate how the addition of Sonic Healthcare to your portfolios can decrease your overall portfolio volatility.